The safe use of drugs on the example of qualitative analysis of opinions of Internet users about drugs containing the recalled valsartan - an exploratory study
-
Copyright
© 2020 PRO MEDICINA Foundation, Published by PRO MEDICINA Foundation
User License
The journal provides published content under the terms of the Creative Commons 4.0 Attribution-International Non-Commercial Use (CC BY-NC 4.0) license.
Authors
Background
The recall of medicines from the pharmaceutical market is one of the most important responsibilities for pharmacists working in community pharmacies ensuring that patients receive medicines of the highest quality and safety. The aim of the study was to evaluate how Internet users in Poland perceived recall of valsartan. The study was conducted as a qualitative analysis of opinions posted on Internet forums. The study is an exploratory in its nature.
Methods
The study was conducted as a qualitative
analysis of opinions posted on Internet forums. Thematic analysis was used and
the data was coded to generate codes and categories, and subsequently to
identify patterns between above-mentioned elements. The initial categories were
organized and aggregated in themes. Posts were coded until theoretical
saturation was achieved. All selected Internet forums were dedicated to
laypeople and professionally-oriented platforms were excluded from our
investigation. Moreover, to achieve full anonymity, we do not provide any
additional details about investigated platforms, e.g. website name.
Results
Three themes were identified: i) impact of falsified medicines on the health status (abbreviated as 'health status'), ii) responsibility of the pharmaceutical industry and government agencies ('responsibility''), iii) legal issues, e.g. consequences and repercussions of introducing poor-quality medicines into routine clinical usage ('legal issues'). In general, posts were highly emotional. Health and responsibility were motives mostly highlighted in posts.
Conclusions
Recall of medicines from the market has been
widely described on the Internet forums. Patients expressed doubts about the
impact of recalled medicines on health, raised the issue of the responsibility
of persons and institutions involved in pharmaceutical distribution, and
finally mentioned legal repercussions of undesirable actions on the
pharmaceutical market. Further, more representative studies are warranted.
INTRODUCTION
The recall of medicines from the pharmaceutical
market is one of the most important responsibilities for pharmacists working in
community pharmacies ensuring that patients receive medicines of the highest
quality and safety, and unwanted medicines are eliminated from
pharmaceutical distribution in a reasonable time [1]. Patients should be convinced that they use medicines produced
aligned with well-accepted standards. On the other hand, the recall of
medicines, particularly when it concerns a significant part of stock available
on the market and is conducted urgently, may affect patients' trust for
treatment, physicians and pharmacists. Community pharmacy is the place in the
chain of pharmaceutical distribution, which is the most crucial in the recall
of medicines, at least from the patients' perspective [2]. Due to the fact that patients have unrestricted access to
pharmacists, in many cases, pharmacists are the first health care providers who
need to answer to patients' fears.
Valsartan, angiotensin
II receptor antagonist widely used for the treatment of high blood pressure and
heart failure, has been commonly used among Polish patients diagnosed with
cardiovascular diseases. Since July 2018, the vast majority of brand products
has been recalled from the Polish market due to contaminated ingredients,
mostly produced in China [3]. This situation was widely discussed in
nationwide media [4,5,6]. Medicines containing valsartan have been
recalled not only from the Polish market, but also from the United Kingdom, and
from the United States of America and was confirmed by an official statement
issued by the European Medicines Agency [7,8,9].
Despite the fact that
patients have access to valsartan provided by other producers under varied
brand names, this recall might have affected patients' attitude to
pharmacotherapy, subsequently leading to lower adherence. With the advent of
new technology, patients can share their opinions and feelings on the Internet
extensively. Although opinions posted on the Internet belong to this part of
society which is able to use new media actively, we cannot underestimate the
Internet as a valuable source of information about patients' feelings in
general [10,11]. Considering that patients' belief might
affect adherence to recommended therapies, Internet forums contain useful
information, which scientists and healthcare providers can use to design more
effective interventions aimed at improving adherence. From a scientific
perspective, studies based on opinions expressed by Internet users have been
more and more frequently conducted recently.
In the light of
above-mentioned issues, the aim of this study was to evaluate how Internet
users in Poland perceived recall of valsartan. The study was conducted as a
qualitative analysis of opinions posted on Internet forums. The study is an
exploratory in its nature.
MATERIALS and METHODS
Since in social studies data used in qualitative research can be defined in various ways, and include a relatively broad spectrum of data, to fulfill the aim of this study, and to adopt a proper methodological approach, we classified posts posted in the Internet forums as a primary unit of investigation. We believe that these kinds of 'documents' can tell us insightful information about social setting and reflects the way in which people perceive a particular problem, in this case, the drug recall from the market. We decided to use a thematic analysis as a method which reduces the amount of data in a systematic and flexible way and is mostly focused on the description of the content, rather than generating new theories or concepts. The researchers investigated forums to find rich cases providing new insights and widen researchers’ perspectives on the aim of the study. Only posts that were classified as ‘rich’ were copied and analyzed. At the initial stage, extracted posts (60 posts) were coded in order to generate codes and categories, and subsequently to identify patterns between the above-mentioned elements. In order to generate codes and categories correctly and immerse deeply in collected materials, our search was based on the ‘semantically meaningful units’, predominantly words, phrases, and sentences underlying the aim of our study. Moreover, we analyzed almost solely contextual context. Textual (linguistics) context is highlighted only if it is necessary to understand more nuanced messages. The initial categories were organized and aggregated in themes. Codes and categories were identified separately by the members of the research team (DŚ, PM) and discussed collectively until consensus regarding themes was achieved. A constant comparison approach was used during the whole procedure. As it is widely used in a qualitative study, we collected posts until new categories were not generated (theoretical saturation) [12,13]. Categorization was immersed in an inductive approach and we based purely on topics revealed from analyzed material.
To maintain high ethical
standards, we decided to collect posts only from Internet forums which are
accessible without obligatory registration, both from users' and readers' perspective.
Taking into consideration current ethical standards in social media research,
forums unprotected by passwords with the possibility of open discussion, should
be considered as public Internet space. Since the matter of our study was not
sensitive and we provided an English translation of originally Polish pieces of
texts, fragments were left untouched without paraphrasing [14]. All selected Internet forums were dedicated to laypeople, and
professionally-oriented platforms were excluded from our investigation, a
primary exclusion criterion. Internet forums were selected after an initial
screening based on the Google search engine; moreover, the research team agreed
to include in the final analysis all initially selected platforms. In summary, we analyzed five Internet forums. The data was
extracted in the first two weeks of May 2019. Several combinations of search terms were used;
although, valsartan recall should be considered as the most important one (including various brand names instead of the general term). Moreover, to achieve full anonymity, we did not provide any additional details
about investigated platforms, e.g. website name. The extracts were provided
without users' login; moreover, due to the fact that the lexical form of verbs
in the Polish language makes it possible to distinguish gender, in order
to achieve full anonymity we decided to unify the gender and not to distinguish
it in the translations into English. To describe our findings, we decided to
use the term ‘patient’ not ‘respondent’ or ‘participant’ in order to emphasize
the clinical significance and to emphasize humanistic approach so important in
qualitative inquiries. When necessary, the vulgarisms and obscene expressions
were removed from the extracts. All trade names and producers were deleted from
extracts. Extracts were translated by a bilingual person, American Native
Speaker (L1 English, L2 Polish), with medical background and both clinical and
scientific experience. The study used the term recall/recalled, the strictly
correct term, describing recall based on temporary safety, which can be
contrasted with the full withdrawal, as in the case of Rofecoxib withdrawn from
the market due to serious cardiovascular adverse events [15].
RESULTS
In general, posts were
highly emotional. Patients had a lot of doubts about further treatment, quality
of care, and further pharmacotherapy. Some posts highlighted a lack of drug
quality, both from the perspective of insufficient legal regulations ensuring
the suitable quality of medicines, as well as standards used during
manufacturing and proper supervision provided by external institutions, e.g.
pharmaceutical supervision guaranteed by an authorized national agency. Three
themes were identified: i) impact of falsified medicines on the health status
(abbreviated as 'health status'), ii) responsibility of the pharmaceutical
industry and government agencies ('responsibility''), iii) legal issues, e.g.
consequences and repercussions of introducing poor quality medicines into
routine clinical usage ('legal issues'). Health and responsibility were motives
mostly highlighted in posts. In Table 1, we attached appropriate extracts from
data.
Patients
emphasized the relationship between long-term use of falsified medicines with
potential health-related consequences. In some posts, we can find information
about a different class of medicines, e.g. statins. Patients connected recall
of medicines containing valsartan with the overall lack of evidence-based
recommendations regarding pharmacotherapy. In patients’ opinion, recall leads
to decrease in confidence, even substantial erosion of trust, particularly for
‘big pharma’, the synonym widely used to describe not only the pharmaceutical
industry, but also a connection between pharmaceutical manufacturers and
government, or in wider perspective authorities involved in the drug
supervision. However, some patients were more neutral in their opinions. They
suggested that there was no detailed information about the reason for recall,
even more; there was no established relationship between taking ‘falsified’
medicines and health-related consequences. What is interesting and may have
further scientific and educational consequences, patients linked almost
automatically recall of medicines from the market with falsified medicines,
which is not correct according to the current legal framework existing in
European Union. The recall of medicines due to the lack of quality and
incompatibilities between legal portfolio and production was associated with
the recall of medicines because of the potential risk of falsification, i.e.
introducing to the market illegal medicines of unknown origin. Moreover,
patients considered generic substitution as one of the reasons for drug recall.
The results are summarized in Table 1, extracts from 1 to 7.
The second theme
identified during our investigation is associated with the potential liability
of the pharmaceutical industry. Both themes ‘health status’ and
‘responsibility’ are interconnected. For some patients, the consequence of
taking poor quality medicines may lead to the development of cancer. The legal
liability, however, is not only limited to the pharmaceutical industry, which
is not clearly described by patients, but should be addressed by individual
accountability of persons directly involved in the control of drug quality, or
those who are responsible for lawmaking. The relationship between taking
recalled medicines and occurrence of serious clinical condition, e.g. cancer is
noticed in analyzed material, frequently in terms of the credibility of the
pharmaceutical industry. Finally, some patients indicated that community
pharmacy is the place where recalled medicines should be returned, and
financial compensation should be distributed among patients, at least refund of
medicines value. Pharmacists were considered as health care providers who
should answer this need (Table 1, extracts from 8 to 12).
Finally, legal issues
were one of the most important themes in analyzed data. Patients indicated that
a lawsuit against pharmaceutical companies should be considered as a justified
legal action in order to protect own rights, but also the rights of all
patients who need to be sure that medicines used on the market are safe.
Moreover, the bureaucracy was considered as a reason for the necessity of
introducing medicines obtained manufactured outside Poland borders, in this
case from China. In conclusion, in the patients’ opinion, red tape impeded
innovation in Poland. Once more time, the use of statins was expressly invoked
by patients as an example of abuse against patients due to the ‘big pharma’
manipulation (Table 1, extracts from 13 to 16).
As it was mentioned
before, identified themes are interconnected, and boundaries between them are
sometimes slightly vague, as it may happen in studies immersed in a qualitative
approach. Undoubtedly, fear of the negative effects of medicines on health is
connected with a willingness to take more formal legal actions; this need was
highly anticipated in analyzed material and even in one case patients informed
about a real lawsuit against the pharmaceutical industry. It might seem that
the common denominator is a willingness or, more precisely speaking, a deep
need for searching people or institutions responsible for introducing medicines
of questionable quality into routine clinical settings.
DISCUSSION
Our study revealed that
massive recall of medicines containing valsartan from Polish market has been
noticed by Internet users and is associated with substantial fear and doubts
regarding further treatment and quality of medicines. The study is only
exploratory in its nature and immersed in a qualitative approach, findings
could be considered as a starting point for further research. Apart from
building a more substantiated theoretical background, the study can lead to
more practical implications. We can assume that massive drug recall should be
accompanied by nationwide campaigns aimed at increasing public awareness about
the potential consequences of unexpected actions on the pharmaceutical market.
Whereas drawing up the range of educational campaigns is beyond the scope of
this paper, we should, at least briefly, highlight that community pharmacies
should be considered as the most suitable place for this kind of actions.
Furthermore, among other roles of pharmaceutical care, education has been
widely noticed as one of the most useful from patients’ perspective due to
unrestricted access to pharmacists in the vast majority of well-developed
countries [16].
The study revealed
substantial lack of patients’ trust not only in health care providers but also
in the basis of clinical care – the efficacy and safety of medicines supported
by evidence from clinical trials and post-marketing observation. Halepian et al
confirmed that trust in physicians among patients diagnosed with diabetes
influenced adherence to insulin regimen; patients who trusted physicians had a
lower level of distress and a higher level of adherence score based on results
obtained from the questionnaire Problem Areas in Diabetes Questionnaire (PAID)
[17]. Similar findings were observed in a study
conducted by Linetzky et al who noticed that not only trust in physicians but
the overall quality of the relationship between physicians and patients,
particularly physicians’ commitment, had significantly affected adherence and
achieved outcomes, e.g. glycemic control [18]. Numerous studies are
consistent with this observation, not only among diabetic patients but also
among other chronically ill patients [19,20,21]. Slightly different
findings were observed in the study conducted among HIV-positive patients.
Though a lack of patients’ trust was not associated with better outcomes,
patients with a more positive attitude to health care team had been longer
under specialized HIV care [22]. Further studies are needed to confirm the
relationship between patients’ trust and adherence. Our study, however, might
be considered as a helpful voice in the current discussion.
Careful analysis of
Internet forums can have substantial clinical implications. The analysis of
posts published by sunbed users led to a more serious attitude towards critical
comments from followers of extensive sunbathing and changed the directions of
discussions among those who are involved in promoting pro-healthy life habits [23]. Some patients considered Internet forums as an important source
of information about the disease and the place where those living with the
disease can share experience in an anonymous way [24]. To some extent, we can also assume that Internet forums are the
contemporary ways of exploring own dissatisfaction and distress [25]. In
this case, we observed that patient were eager to share opinions on the legal
consequences of unexpected drug recall, and poor quality of disseminated
medicines.
Some study limitations
should be briefly highlighted. As it was mentioned before, opinion expressed on
the Internet forum might not be representative to the whole generation. Still,
an important part of the population does not have access to the Internet and is
not willing to share their opinions publicly. However, due to the fact that the
study is exploratory, furthermore representative studies are needed in order to
achieve higher generalization. Moreover, the study is immersed in a qualitative
approach; thus, the primary aim of the study is not to collect a large sample
of data, rather to collect rich data supported by ‘thick’ description. The aim
of a qualitative study is to generate a hypothesis, not to test pre-defined
assumptions. Finally, some aspects of the methodology applied in our study are
consistent with techniques typical for grounded theory, e.g. theoretical
saturation. However, it is worth remembering that some features of grounded
theory are used in different qualitative techniques, as in this case. In
addition, comments were translated from Polish into English, which might be
associated with some discrepancies, probably in the semantic context. We tried
to achieve the highest possible quality of translation, which was conducted by
bilingual American Native Speaker (L1 English, L2 Polish), who has lived a
substantial amount of time in both cultures. Moreover, all authors of the current
article are proficient non-native English speaker with clinical and scientific
experience.
CONCLUSIONS
Recall of medicines from
the market has been widely described on the Internet forums. Patients expressed
doubts about the impact of recalled medicines on health, raised the issue of
the responsibility of persons and institutions involved in pharmaceutical distribution,
and finally mentioned legal repercussions of undesirable actions on the
pharmaceutical market. Further, more representative studies are
warranted.
This study did not receive any funding.
LIST of ABBREVIATIONS
HIV - Human
Immunodeficiency Virus
PAID - Problem Areas in
Diabetes Questionnaire
UK – United Kingdom
USA – United States of
America
------
Table 1. Identified themes and extracts from data.
Theme |
Number |
Extracts |
Health
status |
1 |
I always felt bad after taking valsartan, but the
informational leaflet insisted that it was a good medication. I have 3
cancers - in my reproductive organs, breasts and bone. I also used statins
from X Company, also carcinogenic, they kept insisting cholesterol needs to
be gotten rid of, while they made good money off of us. |
2 |
No risk to the patient, but since the results were
out of proper metrics, now the product is disqualified. At the moment, there
is no reason to worry, especially since the medications have put on hold from
being sold and were not immediately recalled from the market. |
|
3 |
I've been using these
medications for about 6 years. What now? Do you even know what you can actually
take? It's a scandal! |
|
4 |
I have already used up two packets from the recalled
series and I am still alive, so what - I should stop taking them now? |
|
5 |
As long as they are only
stopped, not recalled, we do not know what is going on and how it happened.
There is no reason to make a fuss. For 4 years, nothing happened, they were
checked on a regular basis, now some faulty delivery of raw material happened,
what can we do about it... it happens. |
|
6 |
I bought this terrible series
of medication for my whole vacation time. At the pharmacy, they said not to
take it and to go get a new prescription and now I am 500 kilometers from my
family doctor because I went away for the summer. I will be treating myself
with herbal remedies, which cannot hurt me. |
|
7 |
All patients who took medications with valsartan, I
mean these cheap substitutes (proposed in pharmacies) should go for
oncological consultations. Especially the stomach, the liver. Pharmacies must
exchange the medicine for free, but people, be sure they are changing it for
the original medication and not a fake, because this is how it ends later. |
|
Responsbility |
8 |
I have been taking this
medication for many years. We are experimental rats. They're producing these
medications for big money. Doctors are prescribing them to us, because they
also get money from this. Only us - the patients, are the victims. Who will
refund us for the medications purchased? Who will check the side effects of these
Chinese drugs.... While we
believe in them and take them. |
9 |
I have a case with Company X for poisoning me with
cholesterol-lowering drugs. I have had oncological surgeries. Scientists
write that artificial cholesterol lowering is life-threatening, and now it has
happened to me. Now, even high
blood pressure drugs are carcinogenic. |
|
10 |
Absolutely, in each pharmacy
there should be refunds of contaminated medications and a monetary refund. It's
a disgrace that such a rich pharmaceutical industry is able to make such
dirty tricks. Only money matters,
not our health. |
|
11 |
I took drugs recalled from circulation for the past four
years and now what? Who should I blame????? And what about those people who have already taken
this for over two years, I mean, they basically poisoned them. |
|
12 |
It's a scandal. I took medicine X for several years.
No one from GIF controls what is in these drugs? What ingredients, where they
come from? And what? The matter is quiet, and the pharmaceutical concerns,
what about them? And for us, patients? You can't return the medicine to the
pharmacy, I asked today. |
|
Legal
issues |
13 |
Patients should file charges in a group and not
return the medications so that there will be samples for analysis without any
coverup. Pharmaceutical companies are fattened up to the limits, they have
money to pay for it [settlements]. |
14 |
And why have all these regulations, when it ends up with
such cases anyway? After all, it's this excess of bureaucracy that leads to
the fact that companies prefer to import from China. Europe does not produce
anything of value because there are too many restrictions here. |
|
15 |
Poles, start filing court cases for damages. I'm
appealing also to those, who had their cholesterol lowered [with drugs], this
is a crime. Cholesterol can not be killed, and statins according to
Scientists should not be allowed as drugs at all, they are also a poison, but
pharma schemers have now come up with the idea that statins will fight cancer. |
|
16 |
Compensation, for taking poison, I thought I was
curing myself, and I have been poisoning myself for 4 years with this
medication, we should file a collective lawsuit. |
1. Merks P, Swieczkowski D, Cwalina N, Słomiak K,
Jaguszewski M. The disposal of unused and/or out of date medications in the
community pharmacy setting in Poland – a challenge for pharmaceutical public
health and pharmaceutical care. Journal of Health Policy and Outcomes
Research. 2016(2):64-69. doi:10.7365 / JHPOR.2016.2.7.
2. Best practice to optimize continuity of
medicines supply. Irish Pharmaceutical Healthcare Association. April 2008.
Accessed
May 10, 2019.
3. GIF: Kolejne leki na
nadciśnienie zawierające walsartan wstrzymane i wycofane z obrotu ::
MedExpress.pl.
http://www.medexpress.pl/gif-kolejne-leki-na-nadcisnienie-zawierajace-walsartan-wstrzymane-i-wycofane-z-obrotu/72291.
Accessed May 10, 2019.
4. Leki na nadciśnienie
zawierające Walsartan wycofane z obrotu. Nowe decyzje GIF o lekach [LISTA] |
Gazeta Pomorska.
https://pomorska.pl/leki-na-nadcisnienie-zawierajace-walsartan-wycofane-z-obrotu-nowe-decyzje-gif-o-lekach-lista/ar/13314428.
Accessed May 10, 2019.
5. Leki niszczące wątrobę,
czyli chińska afera z walsartanem.
https://www.termedia.pl/mz/Leki-niszczace-watrobe-czyli-chinska-afera-z-walsartanem,30633.html.
Accessed May 10, 2019.
6. GIF: leki z
zanieczyszczonym walsartanem wycofane z obrotu - Z URZĘDU.
http://www.rynekaptek.pl/komunikaty-urzedowe/gif-leki-z-zanieczyszczonym-walsartanem-wycofane-z-obrotu,29627.html.
Accessed May 10, 2019.
7. Valsartan recall: 4 things patients should know
- CNN.
https://edition.cnn.com/2018/07/19/health/valsartan-recall-explainer/index.html.
Accessed May 10, 2019.
8. Widely taken blood pressure drug valsartan
recalled | News | The Times.
https://www.thetimes.co.uk/article/widely-taken-blood-pressure-drug-valsartan-recalled-m2cd37s9x.
Accessed May 10, 2019.
9.
Update on medicines containing valsartan from Zhejiang Tianyu: company no
longer authorised to manufacture valsartan active substance for EU medicines
due to presence of NDMA – European Medicines Agency.
https://www.ema.europa.eu/en/news/update-medicines-containing-valsartan-zhejiang-tianyu-company-no-longer-authorised-manufacture.
Accessed May 10, 2019.
10. Karmen C, Hsiung RC, Wetter T. Screening
Internet forum participants for depression symptoms by assembling and enhancing
multiple NLP methods. Comput Methods Programs Biomed.
2015;120(1):27-36. doi:10.1016/j.cmpb.2015.03.008
11. Jansen NA, Saint Onge JM. An internet forum
analysis of stigma power perceptions among women seeking fertility treatment in
the United States. Soc Sci Med. 2015;147:184-189.
doi:10.1016/j.socscimed.2015.11.002
12. Grossoehme DH. Overview of Qualitative
Research. J Health Care Chaplain. 2014;20(3):109-122.
doi:10.1080/08854726.2014.925660.
13. Hadi MA, José Closs S. Ensuring rigour and
trustworthiness of qualitative research in clinical pharmacy. Int J
Clin Pharm. December 2015. doi:10.1007/s11096-015-0237-6.
14. Townsend L, Wallace C. Social media research: A
guide to ethics. Aberdeen: University of Aberdeen.
15. Onakpoya IJ, Heneghan CJ, Aronson JK.
Post-marketing withdrawal of 462 medicinal products because of adverse drug
reactions: a systematic review of the world literature. BMC Med. 2016:14(10).
doi:10.1186/s12916-016-0553-2.
16. Swieczkowski D, Mogielnicki
M, Cwalina N, et al. Medication
adherence in patients after percutaneous coronary intervention due to acute
myocardial infarction: From research to clinical implications. Cardiol
J. 2013. doi:10.5603/CJ.a2016.0048.
17. Halepian L, Saleh MB, Hallit S, Khabbaz LR.
Adherence to Insulin, Emotional Distress, and Trust in Physician Among Patients
with Diabetes: A Cross-Sectional Study. Diabetes Ther.
2018;9(2):713-726. doi:10.1007/s13300-018-0389-1.
18. Linetzky B, Jiang D, Funnell MM, Curtis BH,
Polonsky WH. Exploring the role of the patient-physician relationship on
insulin adherence and clinical outcomes in type 2 diabetes: Insights from the
MOSAIc study. J Diabetes. 2017;9(6):596-605.
doi:10.1111/1753-0407.12443.
19. Tran DQ, Barry V, Antun A, Ribeiro M, Stein S,
Kempton CL. Physician trust and depression influence adherence to factor
replacement: a single-centre cross-sectional study. Haemophilia.
2017;23(1):98-104. doi:10.1111/hae.13078.
20. Schoenthaler A, Montague E, Baier Manwell L,
Brown R, Schwartz MD, Linzer M. Patient–physician racial/ethnic concordance and
blood pressure control: the role of trust and medication adherence. Ethn
Health. 2014;19(5):565-578. doi:10.1080/13557858.2013.857764.
21. Nguyen GC, LaVeist TA, Harris ML, Datta LW,
Bayless TM, Brant SR. Patient trust-in-physician and race are predictors of
adherence to medical management in inflammatory bowel disease. Inflamm
Bowel Dis. 2009;15(8):1233-1239. doi:10.1002/ibd.20883.
22. Graham JL, Shahani L, Grimes RM, Hartman C,
Giordano TP. The Influence of Trust in Physicians and Trust in the Healthcare
System on Linkage, Retention, and Adherence to HIV Care. AIDS Patient
Care STDS. 2015;29(12):661-667. doi:10.1089/apc.2015.0156.
23. Taylor J, Lamont A, Murray M. Talking about
sunbed tanning in online discussion forums: Assertions and arguments. Psychol
Health. 2018;33(4):518-536. doi:10.1080/08870446.2017.1375496
24. Bhamrah G, Ahmad S, NiMhurchadha S. Internet
discussion forums, an information and support resource for orthognathic
patients. Am J Orthod Dentofac Orthop. 2015;147(1):89-96.
doi:10.1016/j.ajodo.2014.08.020
25. Nemec M, Kolar T, Rusjan B. Online communities
as a new source of exploring patient dissatisfaction. J Health Organ
Manag. 2018;32(8):962-979. doi:10.1108/JHOM-03-2018-0104